UK markets close in 6 hours 6 minutes

BNTX Mar 2023 120.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.96000.0000 (0.00%)
As of 11:30AM EST. Market open.
Full screen
Previous close3.9600
Open4.0500
Bid0.0000
Ask0.0000
Strike120.00
Expiry date2023-03-17
Day's range3.9600 - 4.0500
Contract rangeN/A
Volume5
Open interestN/A
  • Zacks

    Pfizer (PFE) Seeks FDA Nod for Bivalent COVID Jab in Infants

    Pfizer (PFE) and partner BioNTech seek label expansion to use their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in young children under five years.

  • Reuters

    Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

    (Reuters) -Pfizer Inc and its German partner, BioNTech SE, fired back at Moderna Inc on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in Boston federal court and an order that Moderna's patents are invalid and not infringed. Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the COVID-19 pandemic. Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany.

  • Zacks

    BioNTech (BNTX) Inks Research Deal With Ryvu Therapeutics

    BioNTech (BNTX) signs a research collaboration agreement with Ryvu Therapeutics to develop small molecule programs targeting immune modulation in cancer and other diseases. Stock up.